Join to View Full Profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-293-3196
Fax+1 614-293-7526
Dr. Bezerra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2019 - 2022
University of WashingtonResidency, Internal Medicine, 2016 - 2019- University of Washington School of MedicineFellowship, Bmt, 2014 - 2014
University of Sao PauloFellowship, Hematology, 2012 - 2014- University of Sao PauloResidency, Internal Medicine, 2010 - 2012
- Universidade Federal do Rio Grande do NorteClass of 2009, MD
Certifications & Licensure
OH State Medical License 2022 - 2026
MN State Medical License 2019 - 2023
WA State Medical License 2014 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Abstract achievement award American Society of Hematology, 2017
Publications & Presentations
PubMed
- Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis.Kalyan V Nadiminti, Kwang W Ahn, Jinalben Patel, Qinghua Lian, Evandro Bezerra
Transplantation and Cellular Therapy. 2025-08-05 - Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.Fateeha Furqan, Kwang W Ahn, Manmeet Kaur, Jinalben Patel, Stephen Ansell
American Journal of Hematology. 2025-07-01 - Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.John Sharp, Qiuhong Zhao, Timothy J Voorhees, David A Bond, Yazeed Sawalha
British Journal of Haematology. 2025-06-30
Press Mentions
New Analyses Presented at ASH 2023 Support the Potential Long-Term Response and Safety of Kite’s Tecartus® in Patients with Aggressive Blood CancersDecember 13th, 2023
Other Languages
- Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
